Mizuho raised the firm’s price target on Universal Health (UHS) to $267 from $242 and keeps an Outperform rating on the shares. The company reported strong Q3 results and continues to benefit from solid underlying demand trends, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health upgraded to Outperform from Market Perform at Raymond James
- Universal Health price target raised to $231 from $206 at RBC Capital
- Universal Health price target raised to $302 from $280 at UBS
- Universal Health price target raised to $233 from $200 at Morgan Stanley
- Universal Health: Balanced Outlook Amid MSPP Gains and Medicaid Challenges